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EXECUTIVE SUMMARY  
 
Background 
Contraceptive use in Ghana has remained low despite its annual increase since 2012. The 
annual increase has not been commensurate with the improvement in economic 
indicators and the decline in total fertility rate (TFR) within the same period as anticipated. 
Having a high unmet need for family planning (FP) (30% of married women and 40% of 
unmarried sexually active women) suggests that there may be barriers to access and 
uptake of FP. Over time, several policies, including Ghana’s Costed Implementation Plan 
(CIP) from 2015 through 2020 have suggested several FP initiatives to improve 
contraceptive use yet they have not been entirely implemented. Further, although FP was 
included in the health insurance act passed in 2003 (Act 650), amended in 2008 (Act 
753), and revised in 2012 (Act 852), which indicated that healthcare benefits include FP, 
people continue to pay out of pocket for FP services at National Health Insurance Authority 
(NHIA) credentialled facilities because the policy is yet to be implemented. In some 
settings, evidence suggests an increase in contraceptive uptake with the implementation 
of the removal of out-of-pocket (OP) costs for FP services, therefore, embedding an FP 
package into Ghana’s national health insurance scheme may increase uptake of FP 
service and method mix and improve health outcomes. 
Objectives  
The main objective of this study was to assess the impact of the FP Pilot intervention(s), 
namely OP cost removal for FP services, demand generation for FP, and provider training 
on long-acting reversible contraceptives (LARCs) service provision on FP service uptake. 
Specifically, the study investigated: 
i. The impact of the FP Pilot intervention(s) on the total number of new  FP acceptors.  
ii. The impact of the FP Pilot intervention(s) on method-specific new FP acceptors. 
Methods 
The study employed a quasi-experimental time-series design. The overall study period was 
from January 2017 to February 2020 split into two phases: pre-intervention (January 2017 
to April 2018), and intervention period (May 2018 to February 2020). The study used 
monthly FP service data from Ghana Health Service’s District Health Information System 
(DHIMS) for the assessment. Three different interventions were implemented—OP cost 
removal for FP services, demand generation for FP, and provider training on long-acting 
reversible contraceptives (LARCs) in the selected districts. The control districts were 
selected based on their similarity to the intervention districts. Statistical analysis was 
carried out by running controlled interrupted time series (ITS) models to assess the impact 
of the different combinations of the interventions on total new FP service uptake and 
method-specific uptake. 
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Key findings 
Impact of out-of-pocket cost removal for FP services and other interventions on uptake of 
FP and method mix (all seven intervention districts with OP cost removal) 
The difference in the number of new FP acceptors between intervention and control 
districts in the first month of the intervention suggests a positive impact of the intervention 
(but not statistically significant). Further, it was observed that pre-intervention, the total 
number of FP acceptors in both the intervention and control districts were on the decline. 
However, during the intervention period, the rate of increase in new FP acceptors in the 
intervention districts trended higher compared to the control districts, but the differences 
were not statistically significant. There was a statistically significant monthly increase in 
new IUD acceptors throughout the intervention period in the intervention districts 
compared with that of the control districts. Further, there was evidence that during the 
intervention period, the intervention districts saw an increase in the number of new IUD 
acceptors per month compared with the control districts where new IUD acceptors per 
month decreased significantly over the same period. During the intervention period, new 
oral contraceptive acceptors in both the intervention and control districts were on the 
decline but not statistically significant.  
Impact of out-of-pocket cost removal for FP services only on uptake of FP and method 
mix  
Prior to the intervention (out-of-pocket cost removal for FP services only), the number of 
new FP acceptors was on a downward trend in both the intervention and control districts. 
However, the impact of the intervention in the first month was positive, although not 
statistically significant. Throughout the intervention period, new FP acceptors appeared to 
be increasing in the intervention districts and decreasing in the control districts, although 
neither was statistically significant. There was evidence that during the intervention period 
the intervention districts increased in the number of new IUD acceptors. However, in the 
control districts, the number of new IUD acceptors per month trended towards a decrease. 
Also, it was observed that during the intervention period, the number of new oral 
contraceptive acceptors in both the intervention and control districts was on the decline 
although not statistically significant.  
 
 
Impact of out-of-pocket cost removal of FP services, demand generation, and LARC 
training on uptake of FP and method mix  
The number of new FP acceptors in the intervention district significantly increased during 
the intervention period. However, the increase in the control district, during the same 
period was not statistically significant. With respect to IUD acceptors, there was a 
statistically significant increase in the before- and during the intervention period trends in 
the intervention district compared with the control district. After the introduction of the 
intervention, new IUD acceptors in the intervention district increased monthly. Conversely, 
the results showed that the number of new oral contraceptive acceptors in the intervention 
and control districts trended downwards throughout the intervention period. 
Impact of out-of-pocket cost removal for FP services and LARC training (without demand 
generation) on uptake of FP and method mix  
There was a statistically significant positive effect of the intervention during the first 
month. The results also showed that after the first month, the number of new FP acceptors 
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in the intervention district trended downwards, which was similar in the control district 
although not statistically significant. For new IUD acceptors, there was limited evidence 
that the intervention district was different from the control district pre-intervention and in 
the first month of the intervention and similar results were found concerning oral 
contraceptive acceptors.  
Key recommendations 
Based on the findings of the study, the following recommendations are made:  
 The Ministry of Health in collaboration with the National Health Insurance Authority 
and Ghana Health Service should strongly consider implementing the OP cost removal 
for FP services as it increases the uptake of FP and method mix based on the positive 
effect of OP cost removal for FP services on the number of new FP acceptors and 
LARCs acceptors.  
 The minimum package for the scale-up should be OP cost removal for FP services plus 
demand generation activities based on the statistically significant effect of OP cost 
removal for FP services on the number of new FP acceptors and LARCs acceptors. 
 The Ministry of Health in collaboration with the National Health Insurance Authority 
and Ghana Health Service should consider undertaking a needs assessment regarding 
the capacity building of health providers for the provision of LARCs as the findings 
showed an increase in the use of LARCs before scale-up.  
 The Ministry of Health and Ghana Health Service should ensure FP commodity security 
especially LARCs as there was evidence of an increase in LARCs acceptors. 
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1 INTRODUCTION 
1.1 Background  
Although the rate of increase for contraceptive use in Ghana has grown at about three 
percent annually since 20121, use rates remain lower than expected. Unmet need for 
family planning (FP) remains high—30 percent of married and 42 percent of unmarried 
sexually active women who want to avoid or delay pregnancy are not using FP2,3. To reduce 
unmet need for FP, Ghana’s Costed Implementation Plan (CIP) for 2015 through 2020 
recommended several FP interventions, including removal of direct cost barriers to FP 
services to improve access. If the CIP recommendations had been fully implemented, more 
than 2.3 million unintended pregnancies, 800,000 abortions, and 5,000 maternal deaths 
between 2016 and 2020 could have been averted4. The burden of unintended 
pregnancies, unsafe abortion, and maternal mortality fall most heavily on disadvantaged 
populations such as adolescents, the poor, and rural residents5,6. 
Out-of-pocket (OP) costs for FP, particularly for long-acting reversible contraceptives 
(LARCs), can be a barrier to voluntary contraceptive uptake in high-, middle-, and low-
income countries. Evidence from studies of community-based programs that target 
subsidies (e.g., vouchers) to potential FP clients have generally found an increase in FP 
use7,8,9,10. Evidence of the magnitude of OP payments is clear from the 2018 Commodity 
Gap Analysis commissioned by the Reproductive Health Supplies Coalition, which reported 
that 80 percent of annual commodity costs in 135 low- and middle-income countries 
(LMICs) were borne by consumers who bought FP supplies in the private sector11. 
Subsidies, such as vouchers and health insurance, are often associated with lower OP 
expenses for individuals accessing FP services, and the evidence suggest that these 
strategies may accelerate gains in contraceptive prevalence and progress towards 
universal health coverage (UHC)8,12,13. Embedding an FP package into national health 
insurance may improve uptake of FP services.  
In Ghana, the National Health Insurance Act was passed in 2003 (Act 650), amended in 
2008 (Act 753), and revised in 2012 (Act 852), which indicated that healthcare benefits 
include FP. The expectation was that about 800,000 women would be eligible to benefit 
from FP inclusion in the National Health Insurance Scheme (NHIS)14. Although FP was 
                                                                        
 
1  Ahmed S, Choi Y, Rimon JG, Alzouma S, Gichangi P, Guiella G, et al. 2019. Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012 
London Summit on Family Planning: Results from repeated cross-sectional surveys. Lancet Glob Heal 19: 1-8. 
https://linkinghub.elsevier.com/retrieve/pii/S2214109X19302001  
2  Ghana Statistical Service, Ghana Health Service, ICF International. Ghana Health and Demographic Survey 2014. Rockville, Maryland, USA.  
3  Ghana Statistical Service, Ghana Health Service, ICF. Ghana Maternal Health Survey 2017. The DHS Program: Rockville, Maryland, USA; 2018.  
4  Government of Ghana. 2015. Accra: Ghana Health Service. 2015. Washington, DC: Futures Group, Health Policy Project. Ghana Family Planning Costed 
Implementation Plan. www.familyplanning2020.org/sites/default/files/Ghana-Family-Planning-CIP-2016-2020.pdf 
5  Ortayli N, Malarcher S. 2010. Equity Analysis: Identifying Who Benefits from Family Planning Programs. Stud Fam Plan 41(2): 101-108.  
6  Ahmed S, Li Q, Liu L, Tsui AO. 2012. Maternal deaths averted by contraceptive use: an analysis of 172 countries. Lancet 380(9837): 111-125. 
www.sciencedirect.com/science/article/pii/S0140673612604784   
7  Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. 2010. The contraceptive CHOICE project: Reducing barriers to long-acting reversible 
contraception. Am J Obs Gynecol 203(2).  
8  Bellows B, Bulaya C, Inambwae S, Lissner CL, Ali M, Bajracharya A. 2016. Family Planning Vouchers in Low and Middle Income Countries: A Systematic Review. 
Stud Fam Plan 47(4): 357-370. 
www.researchgate.net/publication/310773977_Family_Planning_Vouchers_in_Low_and_Middle_Income_Countries_A_Systematic_Review  
9  Goldin Evans M, Broyles S, Frederiksen B, Gee RE, Phillippi S, Sothern M, et al. 2019. Long-Acting Reversible Contraceptive Utilization After Policy Change 
Increasing Device Reimbursement to Wholesale Acquisition Cost in Louisiana. Am J Obstet Gynecol. 
https://linkinghub.elsevier.com/retrieve/pii/S0002937819305897  
10  Eisenberg D, McNicholas C, Peipert J. 2013. Cost as a Barrier to Long-Acting Reversible Contraceptive Use in Adolescents. J Adoles Health 52 (4): S59-S63. 
11  Reproductive Health Supplies Coalition. 2018. Global Contraceptive Commodity Gap Analysis 2018. Brussels. 
12 Bellows B, Mackay A, Dingle A, Tuyiragize R, Nnyombi W. 2017. Increasing Contraceptive Access for Hard-to-Reach Populations with Vouchers and Social 
Franchising in Uganda. Glob Heal Sci Pract 5(3): 446-455. https://doi.org/10.9745/GHSP-D-17-00065  
13  Ross R, Fagan T, Dutta A. 2018. Is health insurance coverage associated with improved family planning access? A Review of Household Survey Data from 
Seven FP2020 Countries.  
14 FP2020. www.familyplanning2020.org/resources/advocacy-country-spotlight-ghana  
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included in the health insurance Act, people continue to pay for FP products and services 
at NHIA-credentialled facilities because the policy is yet to be implemented in practice. 
Under the leadership of the Ministry of Health (MOH), the National Health Insurance 
Authority (NHIA) in collaboration with the Ghana Health Service (GHS), Marie Stopes 
International-Ghana (MSIG), and Population Council (the Council) started implementing a 
pilot project to remove FP service OP cost. Under this pilot, all modern clinical FP methods 
(e.g., injectable, implant, IUD, and sterilization) were added to the National Health 
Insurance Scheme (NHIS) and expensed by facilities through the claims process. This 
study seeks to assess the impact of the FP Pilot intervention on the uptake of FP services.  
1.2 Study Objectives 
The main objective of this study was to assess the impact of the FP Pilot intervention(s), 
namely OP cost removal for FP services, demand generation for FP, and training on long-
acting reversible contraceptives (LARCs)  methods on FP service uptake. Specifically, the 
study investigated: 
i. The impact of the FP Pilot intervention(s) on the total number of new  FP acceptors; 
and 
ii. The impact of the FP Pilot intervention(s) on method-specific (IUDs, implants, 
injectables, and oral contraceptives15) new FP acceptors. 
1.3 Structure of the Report 
The report is organized into four chapters. The introductory section (Chapter 1) presents 
background information on the subject area, the problem of OP cost being a barrier to low 
uptake of FP in LMICs as well as the importance of embedding an FP package into national 
health insurance. The chapter also highlights the objectives of this study.  
Chapter 2 outlines the methods used for the evaluation of the FP Pilot intervention. The 
study design, the research setting (intervention and control districts), procedures used to 
select study control districts, source of data, statistical analysis, and ethical guidelines are 
presented in this chapter. 
Chapter 3 presents the results on the impact of various combinations of the interventions 
on FP service uptake between January 2017 and February 2020 in the various study 
districts. The impact of OP cost removal for FP services and other interventions (all districts 
with OP cost removal for FP services) on uptake of FP services and method mix is first 
presented. Secondly, the impact of OP cost removal for FP services on uptake of FP and 
method mix is presented. Thirdly, the impact of OP cost removal for FP services, demand 
generation for FP services, and provider training on LARCs on uptake of FP services and 
method mix is outlined. Lastly, the impact of OP cost removal for FP services and provider 
training on LARCs on uptake and method mix are also presented.  
Chapter 4 presents the summary of findings and Chapter 5 presents the conclusions and 
recommendations of the study. 
  
                                                                        
 
15 The FP Pilot intervention did include oral contraceptives, however, it is anticipated that the FP Pilot intervention activities (i.e., awareness creation activities, 
demand generation, and provider training can influence the uptake of other FP methods such as oral contraceptives) 
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2 METHODS 
2.1 Design  
A quasi-experimental times series design, using monthly FP service data from January 
2018 to February 2020, was employed. The quasi-experimental times series design takes 
the form:  
Intervention Group   O1 O2 O3 X O4 O5 O6 
Control Group   O1 O2 O3 - O4 O5 O6 
 
Where:  
 Time  
O An observation measurement, the subscript is used to distinguish one 
observation measurement from another. 
X Intervention(s) (i.e., the OP cost removal for FP services only intervention) 
- No intervention 
2.2 Study Setting  
This analysis was conducted for nine selected intervention and nine control districts in the 
four FP Pilot intervention regions: Upper East, Ashanti, Central, and Volta (see Figure 1).  
FIGURE 1: Map of study regions 
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2.3 Selection of Study Districts  
To reduce threats to validity, the control and intervention districts were as comparable as 
possible based on the following criteria:  
i. The intervention and control districts were in the same region but not contiguous;  
ii. The proportions of rural localities within the intervention and control districts were 
comparable; 
iii. The structures of health facilities providing FP services in the intervention and control 
areas were similar, e.g., if an intervention district had a hospital, the control district 
also had at least one hospital; 
iv. The total fertility rate (TFR) of intervention and control district pairs were similar; and 
v. Proportions of women of reproductive age (WRA) were similar. 
To further assess whether the selected intervention and control districts were similar, 
principal component analysis (PCA) was used (in this case whether they fell into the same 
group). The following variables were used for the PCA; the proportion of the district 
described as rural, number of hospitals, number of health centers and clinics, number of 
CHPS compounds (the lowest tier of health care provision in Ghana), TFR, and proportion 
of WRA. The analysis included all study districts (88 districts) in the four regions where the 
study took place: Ashanti, Central, Upper East, and Volta regions. Generally, the 
intervention and control districts were similar, there were slight variations across a few 
demographic and socioeconomic characteristics. Table 4 shows the list of the nine 
intervention districts with the nine selected control ones. 
2.3.1 Description of the Study Districts 
Table 1 shows the demographic and socio-economic characteristics of the intervention 
and control study districts. The nine districts exposed to the interventions were 
Bolgatanga, Nabdam, Bawku West, Obuasi, Mfantiman, Ekumfi, Upper Denkyira East, 
Upper Denkyira West, and Adaklu. These were matched to the following control districts 
respectively: Bawku Municipality, Builsa South, Builsa North, Asante Akim Central, Agona 
West, Agona East, Gomoa East, Assin South, and Akatsi North, which were not exposed to 
the intervention(s). According to the 2010 Ghana Population and Housing Census, the 
population of the intervention districts ranged from  33,826 (Nabdam) to 168,641 
(Obuasi) while that of the control sites were from 29,777 (Akatsi North) to 207,071 
(Gomoa East). Further, more than half of the districts were rural. Poverty incidence was 
highest in Adaklu (89.7%) and lowest in Upper Denkyira West (3.3%). TFR ranged between 
2.4 and 4.5 births per woman across the study districts. Again, across all districts, at least 
seven out of 10 children ever born survived. In addition, women in their reproductive age 
formed at least four in 10 of the population of females in the districts16. 
  
                                                                        
 
16 Ghana Statistical Service, 2012; Ghana Poverty Mapping Report, 2015 
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TABLE 1: Matched FP Pilot intervention and control districts 
 
Region 
 
Number 
(Match) 
District 
Populati
on 
Poverty 
Index 
Rur
al/ 
Urb
an 
T
F
R 
% 
WR
A 
% of Children 
Surviving 
  
Intervention 
Upper 
East  
1 Bolgatanga 131,550 27.9 Rura
l 
3.
0 
50.
8 
80.2 
2 Nabdam 33,826 63.0 Rura
l 
3.
6 
43.
4 
77.9 
3 Bawku West 94,034 68.1 Rura
l 
3.
7 
42.
8 
78.5 
Ashant
i 
4 Obuasi 168,641 5.3 Urba
n 
2.
7 
55.
7 
88.7 
Central 5 Mfantsiman 144,332 29.8 Urba
n 
3.
4 
49.
7 
83.3 
6 Ekumfi 52,231 48.4 Rura
l 
4.
0 
41.
2 
78.6 
7 Upper 
Denkyira East 
72,810 30.6 Rura
l 
3.
5 
50.
5 
84.9 
8 Upper 
Denkyira 
West 
60,054 3.3 Rura
l 
4.
5 
46.
2 
85.8 
Volta 9 Adaklu 36,391 89.7 Rura
l 
2.
4 
50.
3 
89.3 
  
Control 
Upper 
East  
1 Bawku 
Municipality 
98,538 42.0 Urba
n 
2.
9 
47.
8 
83.4 
2 Builsa South  36,514 84.4 Rura
l 
4.
3 
45.
8 
78.9 
3 Builsa North 56,477 54.3 Rura
l 
3.
6 
45.
8 
79.1 
Ashant
i 
4 Asante Akim 
Central 
71,508 11.5 Urba
n 
3.
2 
42.
4 
88.0 
Central 5 Agona West  115,358 4.4 Urba
n 
3.
1 
48.
3 
82.7 
6 Agona East 85,920 25.4 Rura
l 
4.
0 
45.
4 
84.1 
7 Gomoa East 207,071 14.5 Urba
n 
3.
7 
53.
0 
85.2 
8 Assin South  104,244 23.6 Rura
l 
4.
3 
44.
5 
84.8 
Volta 9 Akatsi North 29,777 26.5 Rura
l 
4.
1 
44.
3 
80.9 
Source: Ghana Statistical Service, 2012; Ghana Poverty Mapping Report, 2015  
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2.4 The FP Pilot Intervention 
In May 2018, under the leadership of the Ministry of Health (MOH), the National Health 
Insurance Authority (NHIA) in collaboration with Ghana Health Service (GHS), Marie Stopes 
International-Ghana (MSIG), and Population Council (PC) launched a pilot to include all 
modern clinical FP methods (e.g., injectable, implant, IUD, sterilization) into the NHI 
benefits package and expensed by facilities through the claims process. The five 
organizations played complementary roles in the implementation of the FP Pilot project as 
follows (Table 2): 
 
TABLE 2: Roles of stakeholders in the FP Pilot Project 
Organization  Role 
Ministry of Health To oversee the implementation of the pilot project 
National Health Insurance 
Authority  
To lead the management of the implementation of 
the pilot project 
Ghana Health Service To coordinate the implementation of the pilot 
project in health facilities and provider training on 
LARCs service provision 
Marie Stopes International 
Ghana 
To provide financial support and coordinating the 
activities of the project 
Population Council To undertake the evaluation of the intervention 
 
The FP Pilot interventions were implemented in 158 public and private NHIA-credentialled 
facilities across the nine intervention districts. Three different interventions were 
implemented—OP cost removal for FP services, demand generation, and provider training 
on long-acting reversible contraceptive (LARC) service delivery (Table 3). Five different 
combinations of the three interventions were implemented in the nine districts: 
i. OP cost removal for FP services + demand generation + LARCs training in one district;  
ii. OP cost removal for FP services + LARCs training in one district; 
iii. OP cost removal for FP services only in five districts; 
iv. Demand generation only in one district; and 
v. LARCs training only in one district. 
In summary, the OP cost removal for FP services package was implemented in seven 
districts, two districts had FP demand generation intervention, and in three districts, 
selected providers were trained on LARCs insertion and removal. The pilot interventions 
started in May 2018 and ended in July 2020. 
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TABLE 3: Interventions implemented in the nine FP Pilot intervention districts 
 
Intervent
ion 
FP Pilot Districts 
Bolgatan
ga 
Nabd
am 
Baw
ku 
West 
Obu
asi 
Mfantsim
an 
Eku
mfi 
Adak
lu 
Upper 
Denky
ira 
East 
Upper 
Denkyir
a West 
OP cost 
removal 
for   
FP 
services 
         
LARCs 
training  
         
Demand 
generati
on 
         
Facilities  30 14 27 14 12 12 13 25 11 
Note: The FP Pilot intervention considered facilities that provide FP services and are credentialled 
by NHIA; Upper Denkyira East and Upper Denkyira West were not included in the analysis for the 
evaluation.  
2.4.1 Description of the Interventions 
Intervention 1: Removal of out-of-pocket costs of FP services  
This was the primary intervention of the FP Pilot. It was implemented in seven districts 
(Bolgatanga, Nabdam, Bawku West, Mfantsiman, Ekumfi, Obuasi, and Adaklu). In Ghana, 
FP services are provided in both public and private healthcare facilities. Because, in 
practice, FP is not fully covered under the NHIS benefit package, clients pay out-of-pocket 
for FP services. The government of Ghana and its development partners procure FP 
commodities (e.g., implants, IUDs, injectables, etc.) and through the Ghana Health Service 
distribution channels, these commodities are distributed to public and private facilities. 
Hence, the OP fee paid by clients does not include the cost of commodities but are fees 
meant to cover the cost of consumables for providing the service, transportation, 
distribution, and storage of commodities. The FP Pilot, therefore sought to remove OP 
payment by asking credentialled public and private healthcare providers to provide clinical 
FP methods (vasectomy, bilateral tubal ligation, implants, IUDs, and injectables) to NHIS 
insured clients and complete the claims forms for submission and reimbursement. 
Intervention 2: LARCs training in selected facilities in pilot and control districts 
This was an additional intervention implemented in three districts (Bolgatanga, Adaklu, 
and Upper Denkyira East) where some providers received LARCs training. The three 
districts were selected for two reasons. The first was that two of these districts (Bolgatanga 
and Upper Denkyira East) were among the districts identified at the start of the pilot with 
a significant lack of FP providers trained in LARCs service provision. The second reason 
was to get a rural perspective of the effect of LARCs training on FP uptake, hence, the 
inclusion of Adaklu district—a predominantly rural district. The LARCs intervention trained 
selected community health nurses (CHNs) and midwives lacking formal training in LARCs 
service provision. The selection of participants was based on a LARCs needs assessment 
  
8 | Research Report 
in the provider baseline survey that identified skills gaps for implant and IUD insertion and 
removal. Due to resource and time constraints, the LARCs training intervention could not 
include all CHNs and midwives lacking implant and IUD insertion and removal in the 3 
districts. Instead, the training selected some of the untrained staff per district so that, 
most, if not all health centers and the district hospitals had at least one FP service provider 
trained and capable of providing LARCs. Table 4 presents the distribution of midwives and 
CHNs by district. 
 
TABLE 4: Number of CHNs and Midwives Training Needs Gap 
 
District Midwives CHNs 
 Total 
numb
er 
Numb
er 
traine
d in 
LARCs 
Number 
untrain
ed in 
LARCs 
Numb
er 
traine
d in 
LARCs 
for the 
pilot 
Total 
numb
er 
Numb
er 
traine
d in 
LARCs 
No. 
untrain
ed in 
LARCs 
Numb
er 
traine
d in 
LARCs 
for the 
pilot 
Bolgatan
ga 
80 52 28 10 140 67 73 15 
Adaklu  13 3 10 10 40 5 35 15 
Upper 
Denkyira 
East 
12 1 11 10 62 38 24 15 
Total    30    45 
 
 
Intervention 3: Demand generation for FP  
The third intervention, demand generation, was implemented in two districts (Bolgatanga 
and Upper Denkyira West). These districts were selected based on the generally low state 
of awareness on FP issues (e.g. unaware of FP importance in family wellbeing, high 
prevalence of myths and misconceptions) identified at the start of the project. The demand 
generation component of this intervention included education activities to address FP 
myths and misconceptions through mass media and other campaigns. 
2.5 Source of Data  
Facility service data on uptake of FP and method mix were extracted from the District 
Health Information Management System (DHIMS) database from January 2017 to 
February 2020 for all the intervention and control districts (data was extracted on the 5th 
February 2021). DHIMS is a nationwide health information data capture system that is 
used to capture service data including FP. 
2.6 Statistical Analysis for Evaluation 
To assess the impact of the FP Pilot on FP service utilization, this study used two outcome 
indicators 1) number of new FP acceptors, and 2) number of new FP acceptors by methods 
(IUDs, implants, injectables, and oral contraceptives). As earlier indicated, the FP Pilot 
considered clinical FP methods (e.g., injectable, implant, IUD, and sterilization). Hence, 
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oral contraceptives were not included in the pilot intervention. However, it is anticipated 
that the FP Pilot intervention activities such as awareness creation (implemented in all 
intervention districts), demand generation (in selected districts), and provider training (in 
selected districts) could have influenced the uptake of other FP methods such as oral 
contraceptives. The overall study period was from January 2017 to February 2020 split 
into two phases: pre-intervention (January 2017 to April 2018), and intervention (May 
2018 to February 2020). The evaluation data was limited to February 2020 because of 
the onset of COVID-19 in March 2020 and its expected impact on FP service uptake. In 
this report, we focus on the new FP acceptors indicator as it is an indicator that signifies 
the potential of an intervention to draw new clients as well as increase in uptake of FP17. 
The interrupted time series (ITS) approach was used to assess the impact of the 
interventions. The controlled ITS (multiple-group analyses) was utilized. The use of the 
control ITS requires similar comparison groups which are not exposed to the intervention 
to analyze a before-after comparison and an intervention-control comparison. The benefit 
of this design is that it helps control for history bias due to time-varying confounders, in 
particular co-interventions and other events concurrent with the intervention. Series of 
controlled ITS segmented ordinary least square regression models were estimated, one 
for each of the two indicators across the different combinations of the interventions using 
the onset month of the FP Pilot interventions (May 2018) as the event. The analyses were 
done using the Prais–Winsten method18. The analyses also took into consideration the 
potential effect of seasonality in FP service utilization on the outcome variables. The 
controlled ITS regression model takes the form:  
𝑌𝑡 = 𝛽0  +  𝛽1𝑇𝑡 +  𝛽2𝑋𝑡 +  𝛽3𝑋𝑡𝑇𝑡 +  𝛽4𝑍 +  𝛽5𝑍𝑇𝑡 + 𝛽6𝑍𝑋𝑡 + 𝛽7𝑍𝑋𝑡𝑇𝑡 + 𝜀𝑡 ----------(2) 
 
Where 𝑌𝑡 is the aggregated outcome variable measured at each equally spaced time point 
𝑡. 𝛽0 represents the intercept or starting level of the outcome variable (estimated number 
of FP acceptors at the beginning of the pre-outbreak period). 𝛽1 estimates the average 
monthly change in the number of FP acceptors until the introduction of the intervention 
(COVID-19). 𝑇𝑡 is the time since the start of the study, 𝛽2 represents the change in the 
level of service use that occurred in the period immediately following the introduction of 
the intervention (compared with the counterfactual), 𝛽3 represents the difference between 
the trend in FP service use pre-COVID-19 (preintervention) and during COVID-19 (during 
intervention) periods. 𝑋𝑡 is a dummy (indicator) variable representing the intervention 
(preintervention periods 0, otherwise 1), 𝑋𝑡𝑇𝑡 is an interaction term and 𝜖𝑡 the random 
error term. 
Further, 𝑍 is a dummy variable denoting the cohort assignment (treatment or control), and 
𝑍𝑇𝑡, 𝑍𝑋𝑡, and 𝑍𝑋𝑡𝑇𝑡 are all interaction terms among previously described variables. 𝛽4 
represents the difference in the level (intercept) of the outcome variable between 
treatment and controls prior to the intervention, 𝛽5 represents the difference in the slope 
(trend) of the outcome variable between treatment and controls prior to the intervention, 
𝛽6 indicates the difference between treatment and control groups in the level of the 
outcome variable immediately following the introduction of the intervention, and 𝛽7 
represents the difference between treatment and control groups in the slope (trend) of the 
                                                                        
 
17 Bertrand, J., Magnani, R. J., & Rutenberg, N. (1994). Handbook of Indicators for Family Planning Program Evaluation. 
http://www.cpc.unc.edu/measure/publications/ms-94-01. 
18 Linden, A. (2015). Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata Journal, 15(2), 480–500. 
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outcome variable after initiation of the intervention compared with pre-intervention. The 
data was analyzed using Stata version 16.  
2.7 Ethical consideration  
Ethical approval was obtained from the Ghana Health Service Ethics Review Committee 
and the Population Council Institutional Review Board. Permission was sought from the 
Family Health Division of Ghana Health Service to use the DHIMs data.  
2.8 Limitations 
Conscious efforts were made to select the most appropriate comparison districts in the 
design phase of the study, but it is possible that the selected comparison districts did not 
serve as the most appropriate counterfactuals as other programs or policy changes may 
have influenced the indicators of interest in the intervention or comparison districts 
differently. This limitation notwithstanding, the statistical analyses are appropriate and 
robust and allow for interpretation of the results to inform policy decision-making.   
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3 RESULTS 
The analyses were conducted in line with the combination of interventions that were 
implemented to assess the impact of the interventions on uptake of FP and method mix. 
The combination of interventions considered in this analysis are (also see Table 3):  
i. OP cost removal for FP services + other interventions (all seven intervention districts 
with OP cost removal); 
ii. OP cost removal for FP services only (five intervention districts); 
iii. OP cost removal for FP services + demand generation + LARCs training (one 
intervention district); and 
iv. OP cost removal for FP services + LARCs training (one intervention district).  
Subsequent sections will assess each of the four different sets of interventions and their 
impact on the number of new  FP acceptors and method-specific new FP acceptors.  For 
each section, the analyses are presented in four parts: 
i. Impact of the intervention(s) on new FP acceptors (total);  
ii. Impact of the intervention(s) on new IUD acceptors;  
iii. Impact of the intervention(s) on new implant acceptors;  
iv. Impact of the intervention(s) on new injectable acceptors; and 
v. Impact (unintended) of the intervention(s) on new oral contraceptive acceptors.  
As it is done in standard reporting of multiple groups ITS, for each FP indicator we present 
the intervention and control group comparison together and report on whether or not there 
was:  
 Any significant difference in the level of the outcome between treatment and control 
districts at baseline; 
 Any significant difference in the slope between intervention and control districts prior 
to the intervention; 
 A significant difference in the level between intervention and control in the period 
immediately following intervention initiation; 
 Any significant difference between intervention and control in the slope after 
initiation of the intervention compared with pre-intervention period; and 
 Long-term effect.  
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3.1 Impact of Out-of-Pocket Cost 
Removal for FP Services and Any 
Other Intervention on Uptake of FP 
and Method Mix (All Seven 
Intervention Districts with OP Cost 
Removal) 
This section examines the impact of OP 
cost removal for FP services and other 
interventions on new FP acceptors as 
well as IUD, implant, injectable, and oral 
contraceptive acceptors. This involves 
all seven intervention districts with OP 
cost removal for FP services compared 
with seven corresponding control 
districts. 
 
3.1.1 Impact on New FP Acceptors  
Table 5 shows findings of the impact of OP cost removal for FP services and any other 
intervention on the number of new FP acceptors (intervention and control districts).  
As shown in Table 5 and Figure 2, before the intervention, the number of new FP acceptors 
in both the intervention and control districts was on the decline but declining at a higher 
rate in the intervention districts (Coef. = -11.3; not significant). In the first month of the 
intervention (May 2018) however, there was a positive effect on the number of new FP 
acceptors in the intervention districts (Coef. = 64.4; not significant). The number of new 
FP acceptors trended towards an increase in the intervention districts pre– and during the 
intervention trend compared with that of control districts (Coef. = 22.4; not significant). 
During the intervention period, the number of new FP acceptors in the intervention districts 
increased at a rate of 9.3 (C.I. = -3.5, 22.1) women per month compared with the control 
districts, which continued to trend downward (Coef. = -1.8) but both were not statistically 
significant. Although the intervention (OP cost removal for FP services and other 
interventions) did not appear to have a statistically significant effect on uptake of 
contraception, it did show improvement in the intervention districts given that prior to the 
intervention, the trend in the number of new FP acceptors was on the downward trend and 
improved drastically during the intervention period. 
 
  
FIGURE 2: Trends in new FP acceptors (January 2017 – 
February 2020) 
 
 
13 | Research Report 
 
 
TABLE 5: ITS parameter estimates for monthly new FP acceptors – seven intervention 
and control districts  
 
 
Variable New FP 
acceptors 
95% C. I. 
Number of new FP acceptors (in control group) in 
Jan. 2017 (β0) 
1084.6*** 989.2,1179.9 
Average monthly change in number of new FP 
acceptors (in control group), Jan. 2017-Apr. 2018 
(β1) 
-8.6 -29.6,12.3 
Change in level of FP acceptors (in control group) 
in May 2018 (β2) 
-56.4 -225.8,113.0 
Change in trend in monthly number of FP 
acceptors (in control group) between Jan. 2017-
Apr. 2018 compared to May 2018-Feb. 2020 (β3) 
6.8 -23.3,36.9 
Difference in number of new FP acceptors 
between intervention and control groups in Jan. 
2017 (β4) 
793.2*** 556.2,1030.2 
Difference in trend in monthly number of new FP 
acceptors between intervention and control 
groups from Jan 2017-Apr. 2020 (β5) 
-11.3 -43.0,20.5 
Difference in the change in level of new FP 
acceptors between intervention and control 
groups in May 2018 (β6) 
64.4 -169.5,298.4 
Difference in change in trend in monthly number 
of new FP acceptors between treatment and 
control from Jan. 2017-Apr. 2018 compared to 
May 2018-Feb. 2020 (β7) 
22.4 -21.8,66.6 
Average monthly change in number of new FP 
acceptors from May 2018-Feb. 2020 (in 
intervention group) 
9.3 -3.5,22.1 
Average monthly change in number of new FP 
acceptors from May 2018-Feb. 2020 (in control 
group) 
-1.8 -12.8,9.1 
Difference 11.1 -5.7,28.0 
rho 0.670  
Durbin-Watson statistic (original)   0.668  
Durbin-Watson statistic (transformed) 1.576  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
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3.1.2 Impact on New IUD and Implant Acceptors 
Table 6 presents results of the impact of OP cost removal for FP services and other 
interventions on new IUD and implant acceptors (intervention and control districts).  
New IUD Acceptors 
Model M1 on Table 6 and Figure 3 show that comparing the intervention and control 
districts, at baseline the difference in the number of new IUD acceptors was significant 
(Coef. = 19.3; C.I. = 14.6, 24.1) with the intervention districts being higher than the control 
districts. The difference in trend in new IUD acceptors between intervention and control 
districts prior to the start of the intervention was statistically significantly different (Coef. 
= -0.8; C.I. =-2.0, 16.3), showing that whereas the number of new IUD acceptors in the 
intervention districts was trending downward, it was trending upward in the control 
districts. Additionally, there was no statistically significant intervention effect during the 
first month of the intervention. However, there was a positive statistically significant 
monthly increase in the pre– and during the intervention trend in the intervention districts 
compared with that of the controls of 1.9 new IUD acceptors (C.I. = 1.1, 2.7). Further, there 
was evidence that during the intervention, the number of new IUD acceptors in the 
intervention districts increased significantly at a rate of 0.9 new IUD acceptors per month. 
But, in the control districts, new IUD acceptors per month was decreasing significantly at 
a rate of 0.2 new IUD acceptors per month over the same period. The difference between 
the intervention and control districts was 1.1 new IUD acceptors per month. The results 
show that the intervention had a significant effect on the number of new IUD acceptors. 
Although there was no immediate effect in the first month of the intervention (OP cost 
removal for FP services and any other intervention), there appeared to be a significant 
long-term positive impact on the number of new IUD acceptors.  
 
New Implant Acceptors 
Model M2 on Table 6 and visualized in Figure 4, show no statistically significant difference 
in new implants acceptors between the intervention and control districts at baseline, in 
the first month of the intervention, and during the intervention period. However, while the 
trend in the intervention districts was gradually increasing during the intervention period 
at a rate of 1.8 new implants acceptors (not significant) per month, in the control districts, 
it was increasing at a rate of 1.2 new implant acceptors (not significant) per month. Even 
though the intervention (OP cost removal for FP services and any other intervention) did 
not have a significant effect on the uptake of implant acceptors, there appears to be some 
marginal improvement during the intervention period.    
FIGURE 4: Trends in new IUD acceptors 
(January 2017 – February 2020) 
 
FIGURE 3: Trends in new implant acceptors 
(January 2017 – February 2020) 
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TABLE 6: ITS parameter estimates for monthly new FP acceptors – seven intervention and 
control districts 
 IUDs (M1) Implants (M2) 
Variable Coef. 95% C. I. Coef. 95% C. I. 
Number of new FP acceptors (in 
control group) in Jan. 2017 (β0) 
2.1 -0.6,4.8 270.4*** 223.7,317.0 
Average monthly change in number 
of new FP acceptors (in control 
group), Jan. 2017-Apr. 2018 (β1) 
0.1 -0.2,0.3 -4.0* -7.9,0.0 
Change in level of FP acceptors (in 
control group) in May 2018 (β2) 
0.7 -1.2,2.6 -14.5 -43.6,14.5 
Change in trend in monthly number 
of FP acceptors (in control group) 
between Jan. 2017-Apr. 2018 
compared to May 2018-Feb. 2020 
(β3) 
-0.3+ -0.5,0.0 5.2* 0.1,10.2 
Difference in number of new FP 
acceptors between intervention and 
control groups in Jan. 2017 (β4) 
19.3*** 14.6,24.1 49.0 -25.7,123.7 
Difference in trend in monthly 
number of new FP acceptors 
between intervention and control 
groups from Jan 2017-Apr. 2020 
(β5) 
-0.8** -1.4,-0.2 7.1 -2.0,16.3 
Difference in the change in level of 
new FP acceptors between 
intervention and control groups in 
May 2018 (β6) 
-4.7 -12.3,2.8 -6.4 -77.4,64.5 
Difference in change in trend in 
monthly number of new FP 
acceptors between treatment and 
control from Jan. 2017-Apr. 2018 
compared to May 2018-Feb. 2020 
(β7) 
1.9*** 1.1,2.7 -6.6 -19.0,5.9 
Average monthly change in number 
of new FP acceptors from May 
2018-Feb. 2020 (in intervention 
group) 
0.9*** 0.5,1.3 1.8 -2.5,6.1 
Average monthly change in number 
of new FP acceptors from May 
2018-Feb. 2020 (in control group) 
-0.2*** -0.3,-0.1 1.2 -0.8,3.2 
Difference 1.1*** 0.7,1.5 0.5 -4.2,5.3 
rho 0.478  0.640  
Durbin-Watson statistic (original)   1.068  0.722  
Durbin-Watson statistic 
(transformed) 
1.682 
 
1.653 
 
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to 
February 2020 
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3.1.3 Impact on New Injectable and Oral Contraceptive Acceptors 
Table 7 presents findings of the impact of OP cost removal for FP services and other 
interventions on new injectable and oral contraceptive acceptors (intervention and control 
districts).  
New Injectable Acceptors 
Comparing intervention and control districts 
(Model M1 on Table 7), there was no statistically 
significant difference in the trend in the number 
of new injectable acceptors pre-intervention. 
However, from Figure 5, it is noticed that pre-
intervention, new injectable acceptors in the 
intervention and control districts showed a 
downward trend, with the intervention districts 
decreasing at a higher rate (Coef. = -9.9; not 
significant).  
 
Whereas there was no statistically significant 
intervention effect during the first month of the 
intervention, there was a marginal positive statistically significant monthly increase in the 
pre– and during intervention trend in the intervention districts compared with that of the 
controls of 17.4 new injectable acceptors (C.I. = -5.9, 40.7). From the results, during the 
intervention period, the number of new injectable acceptors in the intervention districts 
were increasing monthly at a rate of 5.2 new users per month and in the control districts, 
decreasing at a rate of 2.2 new users per month (not significant) (Model M1 on Table 7 
and Figure 5). From the results, the findings showed a marginal improvement in the 
number of new injectable acceptors as there was an improvement in the intervention 
districts during the intervention period.  
 
New Oral Contraceptive Acceptors 
From Model M2 on Table 7, the difference in the 
slope between the intervention and control 
districts pre-intervention was not statistically 
significant (Coef. = -3.3). However, from Figure 6, 
it is found that pre-intervention, the trend in the 
number of new oral contraceptive acceptors was 
decreasing in the intervention districts and 
increasing in the control districts. Additionally, 
there was no statistical evidence of the 
intervention effect in the first month of the 
intervention. Unlike pre-intervention, it is 
observed that during the intervention period, new 
oral contraceptive acceptors in both the intervention and control districts were on the 
decline (not significant) but decreasing at a higher rate in the intervention districts 
compared to the control districts (Figure 6). The findings did not show evidence of the 
intervention having an unintended improvement in the uptake of oral contraception. 
 
  
FIGURE 5: Trends in new injectable acceptors 
(January 2017 – February 2020) 
 
FIGURE 6: Trends in new oral contraceptive 
acceptors (January 2017 – February 2020) 
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TABLE 7: ITS parameter estimates for monthly new FP acceptors – seven intervention 
and control districts 
 
 
 Injectables (M1) 
Oral contraceptives 
(M2) 
Variable Coef. 95% C. I. Coef. 95% C. I. 
Number of new FP acceptors (in control 
group) in Jan. 2017 (β0) 
598.6**
* 
502.3,694.
8 
65.1**
* 
36.2,93.9 
Average monthly change in number of 
new FP acceptors (in control group), Jan. 
2017-Apr. 2018 (β1) 
-8.9 -20.0,2.2 1.0 -2.2,4.3 
Change in level of FP acceptors (in control 
group) in May 2018 (β2) 
-26.3 -79.0,26.4 -1.0 -23.0,21.0 
Change in trend in monthly number of FP 
acceptors (in control group) between Jan. 
2017-Apr. 2018 compared to May 2018-
Feb. 2020 (β3) 
6.7 -9.1,22.5 -3.0 -7.9,1.8 
Difference in number of new FP acceptors 
between intervention and control groups 
in Jan. 2017 (β4) 
296.4**
* 
162.2,430.
7 
38.5+ -1.7,78.8 
Difference in trend in monthly number of 
new FP acceptors between intervention 
and control groups from Jan 2017-Apr. 
2020 (β5) 
-9.9 -25.5,5.6 -3.3 -7.5,1.0 
Difference in the change in level of new 
FP acceptors between intervention and 
control groups in May 2018 (β6) 
11.2 -72.9,95.3 -2.5 -29.2,24.1 
Difference in change in trend in monthly 
number of new FP acceptors between 
treatment and control from Jan. 2017-
Apr. 2018 compared to May 2018-Feb. 
2020 (β7) 
17.4+ -5.9,40.7 4.2 -1.8,10.3 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in intervention group) 
5.2 -3.6,13.9 -1.0 -2.6,0.5 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in control group) 
-2.2 -8.1,3.6 -2.0 -4.5,0.5 
Difference 7.4 -3.1,17.9 1.0 -1.9,3.9 
rho 0.768  0.703  
Durbin-Watson statistic (original) 0.460  0.613  
Durbin-Watson statistic (transformed) 1.235  1.542  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
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3.2 Impact of Out-of-Pocket Cost Removal for FP Services Only on Uptake 
of FP and Method Mix (Five Intervention Districts) 
This section examines the impact of OP cost 
removal for FP services on new FP acceptors, and 
also on IUD, Implant, Injectable, and oral 
contraceptive acceptors. This involves the five 
intervention districts where OP cost removal for 
FP services only was implemented compared with 
the five corresponding control districts. 
3.2.1 Impact on New FP Acceptors  
Table 8 presents results of the impact of OP cost 
removal for FP services only on new FP acceptors 
(intervention and control districts). 
Comparing the intervention and control districts 
(Table 8), new FP acceptors were significantly higher in the intervention districts compared 
to the control districts at baseline (Coef. =839.6; C.I. = 604.9, 1074.3), however, the trend 
over the pre-intervention period between the intervention and control districts was not 
significantly different. The impact of the intervention in the first month appeared to be 
positive, although not significant (Coef. 63.0; C.I. -145.1, 271.1). Worth noting however is 
that unlike the pre-intervention downward trend in both intervention and control districts, 
during the intervention period, new FP acceptors appeared to be increasing at a rate of 
7.8 new FP acceptors in the intervention districts and continued on a declining trend in 
the control districts at a rate of 1.5 new FP acceptors (not significant) (also Figure 7). The 
impact of OP cost removal for FP services only appeared to have had a positive impact on 
uptake of FP services as it showed noticeable improvement during the intervention period 
(although not statistically significant).  
  
FIGURE 7: Trends in new FP acceptors 
(January 2017 – February 2020) 
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TABLE 8: ITS parameter estimates for monthly new FP acceptors – five intervention and 
control districts 
 
  
Variable New FP acceptors 95% C. I. 
Number of new FP acceptors (in control 
group) in Jan. 2017 (β0) 
771.6*** 656.1, 887.0 
Average monthly change in number of new 
FP acceptors (in control group), Jan. 2017-
Apr. 2018 (β1) 
-9.2 -27.1, 8.6 
Change in level of FP acceptors (in control 
group) in May 2018 (β2) 
-34.7 -174.5, 105.2 
Change in trend in monthly number of FP 
acceptors (in control group) between Jan. 
2017-Apr. 2018 compared to May 2018-
Feb. 2020 (β3) 
7.7 -17.8, 33.3 
Difference in number of new FP acceptors 
between intervention and control groups in 
Jan. 2017 (β4) 
839.6*** 604.9, 1074.3 
Difference in trend in monthly number of 
new FP acceptors between intervention and 
control groups from Jan 2017-Apr. 2020 (β5) 
-10.9 -39.6, 17.8 
Difference in the change in level of new FP 
acceptors between intervention and control 
groups in May 2018 (β6) 
63.0 -145.1, 271.1 
Difference in change in trend in monthly 
number of new FP acceptors between 
treatment and control from Jan. 2017-Apr. 
2018 compared to May 2018-Feb. 2020 
(β7) 
20.2 -19.7, 60.1 
Average monthly change in number of new 
FP acceptors from May 2018-Feb. 2020 (in 
intervention group) 
7.8 -4.6, 20.3 
Average monthly change in number of new 
FP acceptors from May 2018-Feb. 2020 (in 
control group) 
-1.5 -11.6, 8.6 
Difference 9.3 -6.7, 25.4 
rho 0.676  
Durbin-Watson statistic (original)   0.653  
Durbin-Watson statistic (transformed) 1.555  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
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3.2.2 Impact on New IUD and Implant 
Acceptors  
Table 9 presents results of the impact of OP cost 
removal for FP services only on new IUD and 
implants acceptors (intervention and control 
districts).  
New IUD Acceptors 
From Model M1 (Table 9) visualized in Figure 8, 
the intervention and control districts were 
significantly different at baseline. The trend over 
the pre-intervention period between the 
intervention and control districts was significantly 
different (Coef. = -0.8; C.I. -1.4, -0.2), indicating 
that the number of new IUD acceptors in the 
intervention districts was declining at a higher 
rate compared to the control districts. There was 
no statistically significant intervention effect 
during the first month of the intervention (Coef. = 
-3.6; C.I.=-10.9, 3.7). However, there was 
evidence of an increase during the intervention 
period in the intervention districts compared with 
that of the controls by 1.7 new IUD acceptors. 
Although not statistically significant, it appears 
that during the intervention period, the number of 
new IUD acceptors in the intervention districts 
increased at a rate of 0.8 per month. In the control districts however, the number of new 
IUD acceptors per month was decreasing by 0.1 per month though not significant. The 
results showed a noticeable significant difference between the intervention and control 
districts at baseline and the pre-intervention period, showing that uptake of IUD was 
significantly declining in the intervention districts. However, in the intervention period, 
there was an improvement in the uptake of IUD services, while uptake of IUD services 
trended downward.   
New Implant Acceptors 
From Model M2 on Table 9 (also see Figure 9), the results show no statistically significant 
difference in the number of new implant acceptors comparing the intervention with control 
districts. However, while the trend in the intervention districts was increasing at a rate of 
1.4 per month during the intervention period (not significant), in the control districts, new 
implants acceptors were decreasing at a rate of 0.4 women per month (not significant). 
The intervention (OP cost removal only) did not appear to have improved the uptake of 
implants.   
 
  
FIGURE 8: Trends in new IUD acceptors 
(January 2017 – February 2020) 
 
FIGURE 9: Trends in new implant acceptors 
(January 2017 – February 2020) 
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TABLE 9: ITS parameter estimates for monthly new FP acceptors - five intervention and 
control districts 
 
 
 IUDs (M1) Implants (M2) 
Variable Coef. 95% C. I. Coef. 95% C. I. 
Number of new FP acceptors (in control 
group) in Jan. 2017 (β0) 
1.7 -1.1, 4.5 167.0*** 
136.9, 
197.1 
Average monthly change in number of 
new FP acceptors (in control group), Jan. 
2017-Apr. 2018 (β1) 
0.0 -0.2, 0.3 -2.6* -5.0, -0.2 
Change in level of FP acceptors (in 
control group) in May 2018 (β2) 
0.3 -2.4, 3.1 -0.9 -17.6, 15.9 
Change in trend in monthly number of FP 
acceptors (in control group) between 
Jan. 2017-Apr. 2018 compared to May 
2018-Feb. 2020 (β3) 
-0.1 -0.4, 0.2 2.2 -1.0, 5.4 
Difference in number of new FP 
acceptors between intervention and 
control groups in Jan. 2017 (β4) 
18.7*** 
14.0, 
23.4 
56.2+ -3.2, 115.5 
Difference in trend in monthly number of 
new FP acceptors between intervention 
and control groups from Jan 2017-Apr. 
2020 (β5) 
-0.8** -1.4, -0.2 5.7 -2.1, 13.5 
Difference in the change in level of new 
FP acceptors between intervention and 
control groups in May 2018 (β6) 
-3.6 
-10.9, 
3.7 
-23.2 -79.6, 33.2 
Difference in change in trend in monthly 
number of new FP acceptors between 
treatment and control from Jan. 2017-
Apr. 2018 compared to May 2018-Feb. 
2020 (β7) 
1.7*** 0.9, 2.5 -3.9 -14.9, 7.1 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in intervention group) 
0.8 0.4, 1.2 1.4 -2.6, 5.5 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in control group) 
-0.1 -0.2, 0.0 -0.4 -1.7, 1.0 
Difference 0.9 0.5, 1.3 1.8 -2.4, 6.0 
rho 0.529  0.681  
Durbin-Watson statistic (original)   1.026  0.649  
Durbin-Watson statistic (transformed) 1.724  1.600  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to 
February 2020 
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3.2.3 Impact on new Injectable and Oral 
Contraceptive Acceptors 
Table 10 presents results of the impact of OP cost 
removal only on new injectable and oral 
contraceptive acceptors (intervention and control 
districts). 
 
New Injectable Acceptors 
Comparing the intervention and control districts 
(M1 on Table 10), prior to the intervention, the 
trends in the number of new injectable acceptors 
were declining in both the intervention and 
control districts. During the intervention period 
however, the number of new injectable acceptors 
in the intervention districts showed an upward 
trend, increasing at a rate of 4.5 new acceptors 
per month, while the control districts continued to 
decline at a rate of -0.6 new acceptors (not 
statistically significant) (Figure 10). There is some 
evidence, though not statistically significant to 
show that the intervention (OP cost removal only) 
did have a positive impact on injectable 
acceptors as there was noticeable improvement 
during the intervention period.  
New Oral Contraceptive Acceptors 
With respect to the number of new oral contraceptive acceptors, the intervention and 
control districts (M2 on Table 10), new oral contraceptive acceptors were not significantly 
different pre-and during the intervention period. However, it was observed that during the 
intervention period, the number of new oral contraceptive acceptors in both the 
intervention and control districts continued to decline although not statistically significant 
(Figure 11).  
 
  
FIGURE 10: Trends in new Injectable acceptors 
(January 2017 – February 2020) 
 
FIGURE 11: Trends in new oral contraceptive 
acceptors (January 2017 – February 2020) 
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TABLE 10: ITS parameter estimates for monthly new FP acceptors – five intervention 
and control districts 
 
 
 
 
 
 Injectables Oral contraceptives 
Variable Coef. 95% C. I. Coef. 95% C. I. 
Number of new FP acceptors (in control 
group) in Jan. 2017 (β0) 
429.6*** 
325.0, 
534.2 
34.3*** 22.3, 46.4 
Average monthly change in number of 
new FP acceptors (in control group), 
Jan. 2017-Apr. 2018 (β1) 
-9.9* -19.0, -0.8 0.3 -1.5, 2.2 
Change in level of FP acceptors (in 
control group) in May 2018 (β2) 
-25.5 -57.0, 6.0 -1.2 -13.2, 10.8 
Change in trend in monthly number of 
FP acceptors (in control group) 
between Jan. 2017-Apr. 2018 
compared to May 2018-Feb. 2020 (β3) 
9.3 -2.4, 21.0 -1.4 -4.1, 1.3 
Difference in number of new FP 
acceptors between intervention and 
control groups in Jan. 2017 (β4) 
312.0*** 
172.7, 
451.2 
58.6*** 30.0, 87.2 
Difference in trend in monthly number 
of new FP acceptors between 
intervention and control groups from 
Jan 2017-Apr. 2020 (β5) 
-9.6 -23.4, 4.2 -2.3 -5.4, 0.8 
Difference in the change in level of new 
FP acceptors between intervention and 
control groups in May 2018 (β6) 
36.5 
-31.0, 
103.9 
-4.7 -21.8, 12.4 
Difference in change in trend in 
monthly number of new FP acceptors 
between treatment and control from 
Jan. 2017-Apr. 2018 compared to May 
2018-Feb. 2020 (β7) 
14.7 -5.5, 34.9 2.3 -2.0, 6.7 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in intervention group) 
4.5 -3.9, 12.9 -1.0 -2.5, 0.6 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in control group) 
-0.6 -4.5, 3.4 -1.0 -2.1, 0.0 
Difference 5.1 -4.2, 14.4 0.1 -1.8, 1.9 
rho 0.778   0.734 
Durbin-Watson statistic (original)   0.447   0.585 
Durbin-Watson statistic (transformed) 1.196   1.638 
 
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to 
February 2020 
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3.3 Impact of Out-of-Pocket Cost Removal for FP Services, Demand Generation, 
LARC Training on Uptake of FP and Method Mix (one district)  
This section examines the impact of OP cost removal for FP services, demand generation, 
and LARCs training on new FP, IUD, implant, injectable and oral contraceptive (unintended) 
acceptors. This involves only one intervention district where the three combinations of 
interventions were implemented compared with the corresponding control district. 
 
3.3.1 Impact on New FP acceptors 
Table 11 shows results of the impact of the three 
combinations of the interventions (OP cost 
removal for FP services, demand generation, and 
LARCs training) on new FP acceptors 
(intervention and control districts).  
From Table 11 and Figure 12, the results show no 
evidence of a difference between the intervention 
and control districts with respect to the number 
of new FP acceptors during the pre-intervention 
period. However, the trend in the intervention 
district was significantly increasing during the 
intervention period at a rate of about 2.7 (C.I. = 1.2, 4.3; p<0.001) new FP acceptors. In 
contrast, the increase in the control district, during the intervention period was marginal 
(Coef. = 0.6) and not significant. Although the intervention (OP cost removal for FP 
services, demand generation, and LARCs training) did not have an immediate effect, it 
significantly improved uptake of FP during the intervention period.    
  
FIGURE 12: Trends in new FP acceptors 
(January 2017 – February 2020) 
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TABLE 11: ITS parameter estimates for monthly new FP acceptors – one district 
 
 
  
Variable New FP acceptors 95% C. I. 
Number of new FP acceptors (in control group) in Jan. 
2017 (β0) 236.8*** 
181.9, 291.6 
Average monthly change in number of new FP 
acceptors (in control group), Jan. 2017-Apr. 2018 (β1) 
-0.5 -6.6, 5.6 
Change in level of FP acceptors (in control group) in 
May 2018 (β2) 
-8.7 -47.0, 29.6 
Change in trend in monthly number of FP acceptors (in 
control group) between Jan. 2017-Apr. 2018 compared 
to May 2018-Feb. 2020 (β3) 
1.1 -6.6, 8.8 
Difference in number of new FP acceptors between 
intervention and control groups in Jan. 2017 (β4) 
-6.0 -62.1, 50.1 
Difference in trend in monthly number of new FP 
acceptors between intervention and control groups 
from Jan 2017-Apr. 2020 (β5) 
0.3 -6.1, 6.8 
Difference in the change in level of new FP acceptors 
between intervention and control groups in May 2018 
(β6) 
-19.9 -62.8, 23.0 
Difference in change in trend in monthly number of new 
FP acceptors between treatment and control from Jan. 
2017-Apr. 2018 compared to May 2018-Feb. 2020 (β7) 
1.8 -6.6, 10.1 
Average monthly change in number of new FP 
acceptors from May 2018-Feb. 2020 (in intervention 
group) 
2.7*** 1.2, 4.3 
Average monthly change in number of new FP 
acceptors from May 2018-Feb. 2020 (in control group) 
0.6 -1.8, 3.0 
Difference 2.1 -0.8, 5.0 
rho 0.634  
Durbin-Watson statistic (original)   0.749  
Durbin-Watson statistic (transformed) 1.626  
 
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
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3.3.2 Impact on New IUD and Implant Acceptors 
Table 12 presents findings of the impact of the three combinations of interventions on 
new IUD and implant acceptors (intervention and control districts).  
 
New IUD Acceptors 
Comparing the intervention and control districts 
(M1 on Table 12), the number of new IUD 
acceptors was on the decrease in the 
intervention district and on the increase in the 
control district before the intervention. While 
there was no statistically significant effect of the 
intervention during the first month, there was a 
statistically significant increase in the number of 
new IUD acceptors in the intervention period in 
the intervention district compared with the 
control district (Coef. = 0.2; C.I. = 0.0, 0.4; p < 
0.05). After the intervention, new IUD acceptors 
in the intervention district increased monthly at a rate of 0.2 new IUD acceptors, and this 
was statistically significant (C.I. = 0.1, 0.3; p < 0.01), while there was no noticeable 
increase in the control sites (Figure 13). The findings show evidence of improvement in 
new IUD acceptors as it improved significantly in the intervention period.  
New Implant Acceptors 
Results from Model M2 (Table 12), prior to the 
intervention, the number of new implants 
acceptors was on the increase in the control 
district and decreasing in the intervention district. 
Additionally, there was no statistically significant 
effect of the intervention during the first month. 
However, the results show that during the 
intervention period, the trend of new implants 
acceptors in the intervention district significantly 
increased monthly at a rate of 1.5 (C.I. = 0.6, 2.4; 
p < 0.01) new acceptors and increased monthly 
at a rate of 2.2 (C.I. = 1.3, 3.1; p < .001) new 
acceptors in the control district (Figure 14). From the results, there is some evidence of 
improvement in the intervention district regarding the number of new implant acceptors 
as it improved from a declining pre-intervention trend to an increasing trend during the 
intervention period.  
 
  
FIGURE 13: Trends in new IUD acceptors 
(January 2017 – February 2020) 
 
FIGURE 14: Trends in new implant acceptors 
(January 2017 – February 2020) 
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TABLE 12: ITS parameter estimates for monthly new FP acceptors – one district 
 
 IUDs (M1) Implants (M2) 
Variable Coef. 95% C. I. Coef. 95% C. I. 
Number of new FP acceptors (in control 
group) in Jan. 2017 (β0) 
0.4 -0.2, 0.9 57.5*** 44.4,
 70.
7 
Average monthly change in number of 
new FP acceptors (in control group), Jan. 
2017-Apr. 2018 (β1) 
0.0 -0.1, 0.1 -0.1 -1.7, 1.6 
Change in level of FP acceptors (in control 
group) in May 2018 (β2) 
-0.5 -1.6, 0.6 -15.2+ -31.7, 1.4 
Change in trend in monthly number of FP 
acceptors (in control group) between Jan. 
2017-Apr. 2018 compared to May 2018-
Feb. 2020 (β3) 
0.0 -0.2, 0.1 2.2* 0.2, 4.3 
Difference in number of new FP acceptors 
between intervention and control groups 
in Jan. 2017 (β4) 
0.4 -1.0, 1.8 22.2** 6.5,
 37.
9 
Difference in trend in monthly number of 
new FP acceptors between intervention 
and control groups from Jan 2017-Apr. 
2020 (β5) 
0.0 -0.2, 0.1 -0.5 -2.4, 1.4 
Difference in the change in level of new 
FP acceptors between intervention and 
control groups in May 2018 (β6) 
0.4 -1.0, 1.8 13.0 -6.8,
 32.
8 
Difference in change in trend in monthly 
number of new FP acceptors between 
treatment and control from Jan. 2017-
Apr. 2018 compared to May 2018-Feb. 
2020 (β7) 
0.2* 0.0, 0.4 -0.2 -2.8, 2.3 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in intervention group) 
0.2** 0.1, 0.3 1.5** 0.6, 2.4 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in control group) 
0.0 0.0, 0.0 2.2*** 1.3, 3.1 
Difference 0.2** 0.1, 0.3 -0.7 -1.9, 0.5 
rho 0.524  0.552  
Durbin-Watson statistic (original)   0.749  0.994  
Durbin-Watson statistic (transformed) 1.626  1.651  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
 
  
28 | Research Report 
3.3.3 Impact on New Injectable and Oral Contraceptive Acceptors 
Table 13 shows findings of the impact of the three combinations of the interventions on 
new injectable and oral contraceptive acceptors (intervention and control districts).  
New Injectable Acceptors 
From Model M1 on Table 13, the intervention did 
not have a statistically significant effect on new 
injectable acceptors pre-and during the 
intervention, comparing the intervention and 
control districts. Although not significant, during 
the intervention period, the number of new 
injectable acceptors was increasing in the 
intervention district (Coef. = 1.0; C.I. = -0.1, 2.1; 
p < 0.1) and continued to decline in the control 
district (Figure 15). In general, the intervention 
did not appear to have a significant impact on the 
number of new injectable acceptors.  
 
New Oral Contraceptive Acceptors 
The results show that in the pre-intervention 
period, the number of new oral contraceptive 
acceptors was on the decline in the intervention 
district and trending upwards in the control 
district (not significant). During the intervention 
period, the number of new oral contraceptive 
acceptors in the intervention district decreased at 
a rate of 0.1 acceptors per month (not 
significant). In the control district, the number of 
new oral contraceptive acceptors trended 
downwards, decreasing at a rate of 0.8 new 
acceptors per month (C.I. = -1.7, 0.1; p < 0.1) 
(Figure 16). Despite the intervention (OP cost removal for FP services, demand generation, 
and LARCs training), the number of new oral contraceptive acceptors trended downwards 
in the intervention and control districts.  
 
  
FIGURE 15: Trends in new injectable acceptors 
(January 2017 – February 2020) 
 
FIGURE 16: Trends in oral contraceptive 
acceptors (January 2017 – February 2020) 
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TABLE 13: ITS parameter estimates for monthly new FP acceptors – one district 
 
 Injectables (M1) Oral contraceptives (M2) 
Variable Coef. 95% C.I. Coef. 95% C.I. 
Number of new FP acceptors (in 
control group) in Jan. 2017 (β0) 
151.3*** 124.1, 178.5 23.6** 7.5,
 39.
7 
Average monthly change in number 
of new FP acceptors (in control 
group), Jan. 2017-Apr. 2018 (β1) 
-0.3 -4.1, 3.5 0.2 -1.7, 2.0 
Change in level of FP acceptors (in 
control group) in May 2018 (β2) 
5.3 -23.2, 33.9 1.3 -11.0,
 13.
5 
Change in trend in monthly number 
of FP acceptors (in control group) 
between Jan. 2017-Apr. 2018 
compared to May 2018-Feb. 2020 
(β3) 
-0.9 -6.0, 4.3 -1.0 -3.5, 1.6 
Difference in number of new FP 
acceptors between intervention and 
control groups in Jan. 2017 (β4) 
-12.4 -40.2, 15.4 -13.4 -30.0, 3.3 
Difference in trend in monthly 
number of new FP acceptors 
between intervention and control 
groups from Jan 2017-Apr. 2020 
(β5) 
0.8 -3.3, 4.8 -0.4 -2.3, 1.5 
Difference in the change in level of 
new FP acceptors between 
intervention and control groups in 
May 2018 (β6) 
-31.8 -63.4, -0.2 -0.7 -13.4,
 11.
9 
Difference in change in trend in 
monthly number of new FP 
acceptors between treatment and 
control from Jan. 2017-Apr. 2018 
compared to May 2018-Feb. 2020 
(β7) 
1.4 -4.2, 7.0 1.1 -1.6, 3.7 
Average monthly change in number 
of new FP acceptors from May 
2018-Feb. 2020 (in intervention 
group) 
1.0+ -0.1, 2.1 -0.1 -0.4, 0.1 
Average monthly change in number 
of new FP acceptors from May 
2018-Feb. 2020 (in control group) 
-1.2 -3.1, 0.8 -0.8+ -1.7, 0.1 
Difference 2.2+ -0.1, 4.4 0.7 -0.3, 1.6 
rho 0.641  0.721  
Durbin-Watson statistic (original)   0.697  0.556  
Durbin-Watson statistic 
(transformed) 
1.530  1.246  
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3.4 Impact of Out-of-Pocket Cost Removal for FP Services and LARCs 
Training on Uptake of FP and Method Mix (one district) 
This section examines the impact of OP cost removal for FP services and LARCs training 
on new FP, IUD, implant, injectable, and oral contraceptive (unintended) acceptors. This 
involves only one intervention district where OP cost removal for FP services and LARCs 
training was implemented compared with the corresponding control district. 
3.4.1 Impact on New FP Acceptors 
Table 14 presents results of the impact of the two 
combinations of the interventions (OP cost 
removal for FP services and LARCs training) on 
new FP acceptors intervention and control 
districts).  
New FP Acceptors 
From Table 14 and Figure 17, there was a 
statistically significant positive effect of the 
intervention on the number of new FP acceptors 
during the first month of the intervention (Coef. = 
26.9; C.I. = 1.1, 52.6; p < .05). However, the 
results further show that during the intervention period, the number of new acceptors in 
the intervention district decreased at a rate of 1.4 new acceptors per month (C.I. -2.3, -
0.5; p<.01). Although there was a similar decline in the control district, it was not 
statistically significant. The findings seem to suggest that in the first month of the 
intervention, there was a significant improvement in FP uptake and subsequently declined. 
This will require further investigation to better understand what may have caused the 
number of new FP acceptors to decline during the intervention period.  
 
  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to 
February 2020 
FIGURE 17: Trends in new FP acceptors 
(January 2017 – February 2020) 
 
 
31 | Research Report 
 
TABLE 14: ITS parameter estimates for monthly new FP acceptors – one district 
 
 
 
Variable New FP 
acceptors 
95% C. I. 
Number of new FP acceptors (in control group) in Jan. 
2017 (β0) 79.6*** 
48.4, 110.9 
Average monthly change in number of new FP 
acceptors (in control group), Jan. 2017-Apr. 2018 (β1) 
1.0 -1.8, 3.9 
Change in level of FP acceptors (in control group) in 
May 2018 (β2) 
-18.2+ -39.9, 3.5 
Change in trend in monthly number of FP acceptors (in 
control group) between Jan. 2017-Apr. 2018 compared 
to May 2018-Feb. 2020 (β3) 
-1.8 -5.8, 2.2 
Difference in number of new FP acceptors between 
intervention and control groups in Jan. 2017 (β4) 
-43.0* -75.7,-10.3 
Difference in trend in monthly number of new FP 
acceptors between intervention and control groups 
from Jan 2017-Apr. 2020 (β5) 
-0.7 -3.9, 2.5 
Difference in the change in level of new FP acceptors 
between intervention and control groups in May 2018 
(β6) 
26.9* 1.1, 52.6 
Difference in change in trend in monthly number of new 
FP acceptors between treatment and control from Jan. 
2017-Apr. 2018 compared to May 2018-Feb. 2020 (β7) 
0.1 -4.4, 4.5 
Average monthly change in number of new FP 
acceptors from May 2018-Feb. 2020 (in intervention 
group) 
-1.4** -2.3, -0.5 
Average monthly change in number of new FP 
acceptors from May 2018-Feb. 2020 (in control group) 
-0.8 -3.0, 1.4 
Difference -0.6 -3.0, 1.8 
rho 0.570  
Durbin-Watson statistic (original)   0.845  
Durbin-Watson statistic (transformed) 1.570  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
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3.4.2 Impact on New IUD and Implant 
Acceptors 
Table 15 shows findings of the impact of the two 
combinations of the interventions (OP cost 
removal for FP services and LARCs training) on 
new IUD and implant acceptors (intervention and 
control districts).  
New IUD Acceptors 
Model M2 on Table 15 shows that the 
interventions did not have a significant effect on 
new IUD acceptors when the intervention district 
was compared with the control district (Figure 
18). During the intervention, while the number of new IUD acceptors was decreasing 
significantly at a rate of 0.1 (C.I. = -0.2, 0.0) per month in the control district, there was no 
statistically significant change in the intervention district.  
 
New Implants Acceptors 
Comparing the intervention and control districts 
(M2 on Table 15), There was a statistically 
significant difference between the intervention 
and control districts at baseline with the control 
district doing better (Coef. = -29.0; C.I. = -56.2, -
1.8). The results show no evidence of positive 
intervention effect during the first month (May 
2018) of the intervention. However, during the 
intervention period, the number of new implant 
acceptors in the intervention district significantly 
decreased at a rate of 1.3 (C.I. = -1.9, -0.7; p 
<0.001), while in the control district the number 
of implant acceptors decreased by 0.5 (C.I. = -1.0, 0.1; p <0.001) per month (Figure 19). 
This requires further investigation to understand the decline in the number of new implant 
acceptors during the intervention period.  
  
FIGURE 18: Trends in new IUD acceptors 
(January 2017 – February 2020) 
 
FIGURE 19: Trends in new implant acceptors 
(January 2017 – February 2020) 
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TABLE 15: Parameter estimates for monthly new FP acceptors – one district 
 
 
 
 IUDs (M1) Implants (M2) 
Variable Coef. 95% C.I. Coef. 95% C.I. 
Number of new FP acceptors (in control 
group) in Jan. 2017 (β0) 
-0.1 -0.5, 0.3 45.7** 20.1, 71.4 
Average monthly change in number of 
new FP acceptors (in control group), Jan. 
2017-Apr. 2018 (β1) 
0.0 -0.1, 0.1 -1.2 -2.9, 0.5 
Change in level of FP acceptors (in control 
group) in May 2018 (β2) 
1.0 -0.4, 2.4 -1.5 -8.2,5.1 
Change in trend in monthly number of FP 
acceptors (in control group) between Jan. 
2017-Apr. 2018 compared to May 2018-
Feb. 2020 (β3) 
-0.1 + -0.3, 0.0 0.7 -1.1, 2.6 
Difference in number of new FP acceptors 
between intervention and control groups 
in Jan. 2017 (β4) 
0.3 -0.5, 1.1 -29.0* -56.2, -1.8 
Difference in trend in monthly number of 
new FP acceptors between intervention 
and control groups from Jan 2017-Apr. 
2020 (β5) 
0.0 -0.1, 0.1 1.7 -0.6, 4.0 
Difference in the change in level of new 
FP acceptors between intervention and 
control groups in May 2018 (β6) 
-1.1 -2.8, 0.6 8.8 -3.8, 21.4 
Difference in change in trend in monthly 
number of new FP acceptors between 
treatment and control from Jan. 2017-
Apr. 2018 compared to May 2018-Feb. 
2020 (β7) 
0.0 -0.2, 0.3 -2.5+ -5.3, 0.2 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in intervention group) 
0.0 -0.1, 0.0 -1.3*** -1.9, -0.7 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in control group) 
-0.1* -0.2, 0.0 -0.5+ -1.0, 0.1 
Difference 0.0 -0.1, 0.1 -0.8+ -1.6, 0.0
  
rho 0.658  0.661  
Durbin-Watson statistic (original)   0.744  0.702  
Durbin-Watson statistic (transformed) 1.734  1.345  
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
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3.4.3 Impact on New Injectables and Oral 
Contraceptive Acceptors 
Table 16 presents findings of the impact of the 
two combinations of the interventions (OP cost 
removal for FP services and LARCs training) on 
new injectable and oral contraceptive 
(unintended) acceptors (intervention and control 
districts).  
New Injectables Acceptors 
 Comparing the intervention and control districts 
(M1 on Table 16), there was a statistically 
significant difference between the intervention 
and control districts at baseline (Coef. = -5.4; C.I. 
= -8.9, -0.2; p < 0.01).  Before the intervention, 
there was also a statistically significant difference 
between the slope of the intervention and control 
districts, with the control district having a higher 
number of new injectables acceptors (Coef. = -
0.9; C.I. = -1.6, -0.2; p < 0.01). The results 
showed evidence of positive intervention effect 
during the first month (May 2018) of the 
intervention (Coef. = 9.3; C.I. = 1.4, 17.2; p < 
0.05). During the intervention period, the number 
of new injectables acceptors in the intervention 
district significantly decreased at a rate of 0.5 
new injectables acceptors per month (C.I. = -0.8, 
-0.2; p < 0.05). Although the number of new 
injectable acceptors in the control district was also decreasing but not significantly (Figure 
20). While the intervention appeared to have a significant effect in the first month of the 
intervention, it declined thereafter, which requires further investigation to understand the 
decrease in trend.  
New Oral Contraceptive Acceptors 
From Model M2 on Table 16, the results show that the intervention did not have any 
unintended significant impact on the number of new oral contraceptive acceptors 
comparing the intervention to the control districts (Figure 21).  
 
 
 
  
FIGURE 20: Trends in new injectable acceptors 
(January 2017 – February 2020) 
 
FIGURE 21: Trends in new oral contraceptive 
acceptors (January 2017 – February 2020) 
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TABLE 16: Parameter estimates for monthly new FP acceptors – one district 
 
 
 Injectables (M1) Oral contraceptives 
(M2) 
Variable Coef. 95% C. I. Coef. 95% C. I. 
Number of new FP acceptors (in control 
group) in Jan. 2017 (β0) 
20.0*** 17.3, 22.8 7.2** 2.5,
 12.
0 
Average monthly change in number of 
new FP acceptors (in control group), 
Jan. 2017-Apr. 2018 (β1) 
1.2*** 0.6, 1.7 0.6+ -0.1, 1.3 
Change in level of FP acceptors (in 
control group) in May 2018 (β2) 
-9.2** -16.1, -2.4 -2.7 -10.1, 4.8 
Change in trend in monthly number of 
FP acceptors (in control group) between 
Jan. 2017-Apr. 2018 compared to May 
2018-Feb. 2020 (β3) 
-1.5** -2.6, -0.4 -0.7 -2.2, 0.8 
Difference in number of new FP 
acceptors between intervention and 
control groups in Jan. 2017 (β4) 
-5.4** -8.9, -2.0 -5.9* -10.8, -
1.1 
Difference in trend in monthly number 
of new FP acceptors between 
intervention and control groups from 
Jan 2017-Apr. 2020 (β5) 
-0.9** -1.6, -0.2 -0.6+ -1.3, 0.1 
Difference in the change in level of new 
FP acceptors between intervention and 
control groups in May 2018 (β6) 
9.3* 1.4, 17.2 3.1 -4.4, 10.7 
Difference in change in trend in monthly 
number of new FP acceptors between 
treatment and control from Jan. 2017-
Apr. 2018 compared to May 2018-Feb. 
2020 (β7) 
0.8 -0.5,2.0 0.8 -0.7, 2.3 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in intervention group) 
-0.5** -0.8, -0.2 0.1 0.0, 0.2 
Average monthly change in number of 
new FP acceptors from May 2018-Feb. 
2020 (in control group) 
-0.3 -1.1, 0.4 -0.1 -1.2, 1.0 
Difference -0.1 -1.0, 0.7 0.2 -0.9, 1.3 
rho 0.545  0.512  
Durbin-Watson statistic (original)   0.872  0.979  
Durbin-Watson statistic (transformed) 1.785  1.613  
 
Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 
to February 2020 
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4 SUMMARY  
The evaluation assessed the impact of the various combinations of interventions that were 
implemented on the number of new FP acceptors and method-specific new FP acceptors. 
The combinations of interventions considered in this analysis were:  
i. OP cost removal for FP services + other intervention (all seven intervention districts 
with OP cost removal for FP services); 
vi. OP cost removal for FP services only (five intervention districts); 
vii. OP cost removal for FP services + demand generation + LARCs training (one 
intervention district); and 
viii. OP cost removal for FP services + LARCs training (one intervention district).  
Findings from the ITS analyses show that three of the four combinations of interventions, 
in general, appeared to have positive impacts on uptake of FP services and method mix. 
Except for OP cost removal for FP services and LARCs training only (without demand 
generation) combination of the intervention, all the other combinations showed positive 
impacts on the overall uptake of FP services as well as on method-specific uptake. There 
was also evidence of an increase in the use LARCs and a decrease in the use of short-
term methods. The relative weakness of OP cost removal and LARC Training as an 
intervention needs to be investigated further.  
 
 
  
Summary table of the impact of the combinations of interventions on the various FP indicators 
  
Indicator  OP cost 
removal and 
other 
interventions 
(all seven 
intervention 
districts with 
OP cost 
removal) 
 OP cost 
removal only 
OP cost 
removal for FP 
services, 
demand 
generation, 
and LARCs 
training 
 OP cost 
removal and 
LARCs 
training 
New FP acceptors  Positive impact  Positive 
impact 
Positive 
impact+ 
 No positive 
impact 
New IUD 
acceptors 
 Positive 
impact+ 
 Positive  
impact+ 
Positive 
impact+ 
 No positive 
impact 
New implant 
acceptors 
 Positive impact  Positive 
impact 
Positive 
impact+ 
 No positive 
impact 
New injectable  Positive 
impact+ 
 Positive 
impact 
Positive 
impact+ 
 No positive 
impact 
        
New oral 
contraceptive# 
 No positive 
impact 
 No positive 
impact 
No positive 
impact 
 Positive 
impact 
 
Note: + = Significant; # examined whether the intervention(s) had unintended effects on uptake of 
oral contraceptives  
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5 CONCLUSION AND RECOMMENDATIONS  
4.1 Conclusion 
This report presents an evaluation of the impact of the various combination of FP Pilot 
intervention on FP service uptake and methods. Generally, the various combinations of 
interventions appeared to lead to an increase in the uptake of new FP acceptors. Although 
not statistically significant in some cases, it showed positive impacts in the first month of 
the intervention and/or an increase in the number of new FP acceptors during the 
intervention period compared to the pre-intervention period in the intervention district(s) 
relative to the control district(s). In some cases, the results showed that the interventions 
had a positive effect after the introduction of the intervention comparing the intervention 
to the control districts.  
However, there was no surge in uptake of contraceptives immediately after cost removal. 
The increases were gradual and progressive. In effect, cost removal did not result in a 
spike in service utilization that could potentially overwhelm the health system, as was 
initially feared. This implies that cost and other resources could be planned accordingly to 
expect a gradual increase in contraceptive use. 
Further, there was evidence of the effect of the intervention showing an increase in the 
number of new long-term methods acceptors, especially IUDs, and a decline in the use of 
oral contraceptives, one of the most popular short-term methods. Overall, there appeared 
to be a sustained decline in the use of short-term methods as more and more women 
opted for long-term methods, mainly IUD. The need to expand the number of providers 
with skills to provide long-term methods becomes critical.  
4.2 Recommendations  
Based on the findings of the study, the following recommendations are made:  
 The Ministry of Health in collaboration with the National Health Insurance Authority 
and Ghana Health Service should strongly consider implementing the OP cost 
removal for FP services as it generally increases the total number of new FP 
acceptors and new LARC acceptors.   
 The minimum package for the scale-up should be OP cost removal for FP services 
plus demand generation activities based on the statistically significant effect of OP 
cost removal for FP services on the number of new FP acceptors and LARCs 
acceptors.  
 The Ministry of Health in collaboration with the National Health Insurance Authority 
and Ghana Health Service should consider undertaking a needs assessment 
regarding the capacity building of health providers for the provision of LARCs as the 
findings showed an increase in the use of LARCs before scale-up.  
 The Ministry of Health and Ghana Health Service should ensure FP commodity 
security especially LARCs as there was evidence of an increase in LARCs acceptors. 
